Generated by GPT-5-mini| European Wound Management Association | |
|---|---|
| Name | European Wound Management Association |
| Abbreviation | EWMA |
| Formation | 1991 |
| Type | Professional association |
| Headquarters | London |
| Region served | Europe |
| Leader title | President |
European Wound Management Association is a professional association focused on advancing wound care across Europe through clinical practice, research, education, and policy. It interfaces with a broad range of organizations including academic institutions, healthcare providers, regulatory bodies, and patient groups to promote evidence-based wound management. The association acts as a hub connecting clinicians, researchers, and industry stakeholders from across the continent and beyond.
Founded in 1991, the association emerged during a period of growing interest in chronic wound care linked to aging populations in United Kingdom, Germany, France, Italy, and Spain. Early contributors included clinicians and researchers associated with institutions such as St Thomas' Hospital, Charité – Universitätsmedizin Berlin, Hôpital Saint-Louis, Policlinico Sant'Orsola-Malpighi Hospital, and Hospital Universitario La Paz. The association developed alongside parallel entities like European Society of Cardiology, European Society for Vascular Surgery, and International Association for the Study of Pain, reflecting cross-disciplinary needs. Key milestones included the establishment of regional working groups connected to World Health Organization initiatives, collaborations with European Commission health programs, and joint activities with national societies such as the British Association of Dermatologists and German Wound Healing Society. Over successive presidential terms influenced by figures from Karolinska Institute, University of Oxford, University of Copenhagen, and Utrecht University, the association expanded its remit to include guideline development, academic networking, and large-scale conferences.
The association's mission emphasizes improving patient outcomes through dissemination of evidence from trials and registries originating in centers like Mayo Clinic, Cleveland Clinic, Karolinska University Hospital, Radboud University Medical Center, and Aarhus University Hospital. Objectives include standardizing clinical pathways informed by research from groups at Imperial College London, Ghent University Hospital, University of Barcelona, and University of Zurich; advocating with policy actors including the European Medicines Agency and European Centre for Disease Prevention and Control; and fostering education in partnership with organizations such as European Federation of Nurses Associations and Association of British Clinical Diabetologists. The association also prioritizes promotion of multidisciplinary approaches referencing practice in Royal Free Hospital, Addenbrooke's Hospital, Sahlgrenska University Hospital, and Leiden University Medical Center.
Membership spans clinicians, nurses, podiatrists, researchers, and industry representatives drawn from institutions such as University College London Hospitals, Hannover Medical School, Hospital Clínic de Barcelona, CHU de Liège, and Trinity College Dublin. Governance is structured with an elected board, scientific advisory panels, and national representatives mirroring systems in European Respiratory Society and European Society of Clinical Microbiology and Infectious Diseases. Leadership roles have been held by academics affiliated with University of Manchester, University of Glasgow, Lisbon University Hospital Center, and University of Helsinki. Committees coordinate finance, ethics, education, and guideline development, with links to professional bodies such as the Royal College of Physicians and European Association of Plastic Surgeons.
Programs include clinical audits modeled on registries like those of Eurostat projects and trials run in collaboration with centers such as Charité, King's College London, and Erasmus MC. Training initiatives mirror curricula from European Board of Surgery programs and involve workshops, fellowships, and exchange placements at hospitals including Hôpital Européen Georges-Pompidou, Rigshospitalet, and Vienna General Hospital. Quality improvement campaigns reference standards promoted by International Council of Nurses and the Organisation for Economic Co-operation and Development. The association runs thematic working groups on topics linked to research at Max Planck Institute for Infection Biology, Institut Pasteur, and Karolinska Institutet.
The association produces consensus documents and guidelines developed through collaborations with academic publishers and journals associated with The Lancet, BMJ, Journal of Wound Care, European Journal of Vascular and Endovascular Surgery, and Nature Reviews Disease Primers. Position statements have been developed in consultation with researchers from University of Edinburgh, University of Padua, University of Warsaw, and University of Groningen. Clinical recommendations reflect evidence from trials conducted at Mayo Clinic, Cleveland Clinic, Mount Sinai Hospital, and major European academic centers, and align with regulatory perspectives from European Medicines Agency. Educational materials are distributed to professional partners including European Wound Ostomy and Continence Nurses Society.
The flagship annual congress attracts delegates and speakers from institutions such as Harvard Medical School, Stanford University, University of Toronto, Karolinska Institutet, and numerous European universities. Sessions frequently feature keynote presentations by specialists affiliated with Royal College of Surgeons of England, European Society of Cardiology, European Society for Vascular Surgery, and International Continence Society. The association organizes specialized courses in collaboration with universities like University of Southampton, University of Basel, and KU Leuven and supports doctoral and postdoctoral training linked to research centers including Wellcome Trust funded groups and EU-funded research consortia.
Partners include international organizations and national societies such as World Health Organization, European Commission, European Medicines Agency, European Academy of Dermatology and Venereology, International Society for Infectious Diseases, European Diabetes Forum, and patient advocacy groups. Research partnerships have been established with universities and institutes like Karolinska Institutet, Imperial College London, Erasmus University Rotterdam, Università degli Studi di Milano, and University of Leeds to run multicenter studies and trials. Industry collaborations involve medical device companies, regulatory agencies, and standards bodies such as European Committee for Standardization to align innovation with clinical needs.
Category:Medical associations based in Europe